BioSpace News Archive

The U.S. Food and Drug Administration today approved three drugs for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch.

WAT Medical is thrilled to announce the newest clinical study conducted for an anti-migraine device by the HeadaTerm, for the treatment of migraines

Today, IntraHealth International’s board of directors announced Polly Dunford will be IntraHealth’s next president and CEO

Wellness brand HUM Nutrition, a leader in the beauty from within category, launches its latest nutritional supplement PRIVATE PARTYTM.

HOPKINTON, Mass., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, today announced its financial results for the fourth quarter and year-ended December 31, 2019 and provided an update on recent corporate and clinical development highlights. “In January, we made the difficult decision to discontinue our development efforts

Premier orthopedic practice will add 27 new providers to Banner’s employed medical group

IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences

BOSTON , Feb. 14, 2020 /PRNewswire/ -- In response to severe storms and flooding in Kentucky , North Carolina , Oregon , Virginia , Washington and West Virginia , Blue Cross Blue Shield of Massachusetts (“Blue Cross”) is expediting access to care for members who may be affected by flooding in these six states. Blue Cross

RB’s accumulated donation exceeds RMB 55 million

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the closing of its previously announced underwritten public offering of 9,230,770 shares of common stock at a public offering price of $1.30 per share.